査読有
doi：10.1002/cam4.5931
PubMed No.：37062077
2021 Impact Factor：4.711
種類：原著
誌名：Cancer Medicine
発行年月：2023年4月
巻号頁：12: 12325-12335, 2023
論題：The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
著者：Shigeo Shimose, Hideki Iwamoto, Tomotake Shirono, Masatoshi Tanaka, Takashi Niizeki, Masahiko Kajiwara, Satoshi Itano, Yoichi Yano, Satoru Matsugaki, Etsuko Moriyama, Yu Noda, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takumi Kawaguchi